Citation Impact
Citing Papers
Comprehensive genomic characterization of head and neck squamous cell carcinomas
2015 StandoutNature
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
2003 Standout
Prevention of cervical cancer through papillomavirus vaccination
2004
Immunology of the human papilloma virus in relation to cancer
1994
Process evaluation within pragmatic randomised controlled trials: what is it, why is it done, and can we find it?—a systematic review
2020
Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer
2001
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
2000 Standout
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Immunosuppressive Tumor Microenvironment in Cervical Cancer Patients
2011
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
2003 Standout
Interferon-? and -?, but not tumor necrosis factor-?, demonstrate immunoregulatory effects on carcinoma cell lines infected with human papillomavirus
1997
Cancer immunotherapy utilizing gene-modified T cells: From the bench to the clinic
2015
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
1999 Standout
Enhancement of the anti-tumor immune response using a combination of interferon-γ and B7 expression in an experimental mammary carcinoma
1998 StandoutNobel
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
2000 Standout
Serologic response in human papillomavirus‐associated invasive cervical cancer
1993
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
Towards vaccines against human papillomavirus type-16 genital infections
1993
Oxidative stress as a mediator of apoptosis
1994 Standout
Papillomavirus vaccines in clinical trials
2003
A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance
2021 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Molecular Pathogenesis of Cancer of the Cervix and Its Causation by Specific Human Papillomavirus Types
1994 StandoutNobel
Human Papillomaviruses and Cervical Cancer
2006
Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression
1995
Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma
1998
Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells
2005 StandoutNobel
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
2001 StandoutNature
A possible role for human papillomaviruses in head and neck cancer
1996
MHC antigens and tumor escape from immune surveillance
2001
Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes
2016 StandoutNobel
Differential sensitivity of human papillomavirus type 16+ and type 18+ cervical carcinoma cells to CD95-mediated apoptosis
2001 StandoutNobel
Relationship Between myc Oncogene Activation and MHC Class I Expression
1992
The Immunobiology of Cancer Immunosurveillance and Immunoediting
2004 Standout
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
1999
Human papillomavirus-related serological markers of invasive cervical carcinoma in Brazil.
1994
Peptide Antimicrobial Agents
2006 Standout
A reassessment of the role of B7-1 expression in tumor rejection.
1995
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
The Three Es of Cancer Immunoediting
2004 Standout
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
2005 Standout
NK CELL RECEPTORS
1998 Standout
Enhancement of Sindbis Virus Self-Replicating RNA Vaccine Potency by Linkage ofMycobacterium tuberculosisHeat Shock Protein 70 Gene to an Antigen Gene
2001 StandoutNobel
Nanomaterials and nanoparticles: Sources and toxicity
2007 Standout
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
Human Papillomavirus and Cervical Cancer
2003 Standout
PAPILLOMAVIRUS BINDING AND ENTRY The heparan sulfate receptor and inhibition by lactoferrin
2005
HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women.
2001
Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirus-immortalized, and carcinoma cell lines.
1993
Tumor necrosis factor a-11 and DR15-DQ6 (B*0602) haplotype increase the risk for cervical intraepithelial neoplasia in human papillomavirus 16 seropositive women in Northern Sweden.
2000
Presence Of Antibodies To Seven Human Papillomavirus Type 16-Derived
1994
Genetic Variants in TAP Are Associated with High-Grade Cervical Neoplasia
2009
Multiple Genetic Alterations Cause Frequent and Heterogeneous Human Histocompatibility Leukocyte Antigen Class I Loss in Cervical Cancer
2000
Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation
1999 StandoutNobel
Works of Mary Connor being referenced
Loss of MHC class‐I expression in cervical carcinomas
1990
Serological responses to HPV 16 in cervical dysplasia and neoplasia: Correlation of antibodies to E6 with cervical cancer
1993
A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding
2015
HLA expression in pre-invasive cervical neoplasia in relation to human papilloma virus infection
1993